Stock listing

NASDAQ:CODX Co-Diagnostics, Inc. Stock

Home listing (NASDAQ) of Co-Diagnostics, Inc.

Follow Co-Diagnostics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CODX

$0.13 USD -0.04 (-21.3%)

Close on Nov 20, 2026

Past year -98.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.128 – $0.142 USDNov 20, 2026
Volume
1.14M sharesNov 20, 2026
Market cap
$1.36M USDAt the close on Nov 20, 2026 · price × 10.51M shares outstanding
52-week range
$0.128 – $13.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$730,291 USDMedian day 313,547 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Co-Diagnostics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CODX · Home$0.13 USD-0.035 (-21.3%)1,143,708$0.14$0.142$0.128$0.165Close on Nov 20, 2026
LSE:0A50$0.13 USD-0.039 (-23.3%)107,164$0.138$0.164$0.125$0.169Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CODX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.13-0.035-21.3%$0.14$0.142$0.1281,143,708
$0.165-0.033-16.7%$0.19$0.19$0.1621,106,485
$0.198+0.002+0.9%$0.196$0.225$0.1841,951,116
$0.196-0.029-12.9%$0.205$0.209$0.172992,914
$0.225-0.034-13.0%$0.25$0.25$0.224591,761
$0.259-0.011-4.1%$0.269$0.269$0.245591,938
$0.27-0.008-2.9%$0.245$0.27$0.2451,218,342
$0.278-0.011-3.8%$0.279$0.295$0.253,888,316
$0.289-0.03-9.5%$0.31$0.335$0.26474,930,648
$0.319+0.062+24.2%$0.273$0.345$0.26224,151,910
$0.257-0.01-3.9%$0.29$0.29$0.245528,878
$0.267-0.094-26.1%$0.376$0.39$0.2651,035,473
$0.361-0.019-4.9%$0.38$0.391$0.355446,394
$0.38+0.027+7.6%$0.39$0.39$0.367354,002
$0.353-0.013-3.7%$0.392$0.418$0.35590,831
$0.367-0.028-7.2%$0.40$0.404$0.365236,047
$0.395-0.046-10.5%$0.449$0.45$0.393553,902
$0.441-0.028-5.9%$0.496$0.496$0.435335,175
$0.469-0.078-14.3%$0.542$0.555$0.4521,233,900
$0.547+0.002+0.3%$0.549$0.578$0.546116,712
$0.546-0.024-4.3%$0.555$0.572$0.525283,788
$0.57-0.072-11.2%$0.63$0.65$0.557531,088
$0.642-0.005-0.8%$0.669$0.67$0.612719,132
$0.647-0.019-2.8%$0.66$0.70$0.607578,522
$0.666+0.012+1.8%$0.642$0.693$0.64269,123
$0.654-0.061-8.5%$0.72$0.75$0.63329,026
$0.715-0.049-6.5%$0.79$0.83$0.711280,833
$0.765-0.301-28.2%$1.06$1.06$0.7461,023,461
$1.065-0.185-14.8%$1.24$1.25$1.06505,922
$1.25+0.13+11.6%$1.12$1.30$1.11652,977
$1.12+0.03+2.8%$1.09$1.13$1.09111,449
$1.09-0.03-2.7%$1.135$1.15$1.08139,908
$1.12-0.03-2.6%$1.10$1.14$1.085187,531
$1.15+0.05+4.5%$1.12$1.17$1.05886,900
$1.10+0.02+1.9%$1.10$1.205$1.081,139,715
$1.080.000.0%$1.08$1.10$1.0683,465
$1.08+0.01+0.9%$1.06$1.09$1.06141,116
$1.070.000.0%$1.08$1.10$1.0587,378
$1.07-0.04-3.6%$1.09$1.10$1.0598,904
$1.11+0.02+1.8%$1.11$1.15$1.08177,026
$1.09-0.06-5.2%$1.15$1.16$1.09189,751
$1.15+0.05+4.5%$1.11$1.17$1.09436,378
$1.10+0.02+1.9%$1.09$1.10$1.06185,325
$1.08+0.07+6.9%$1.02$1.10$0.99356,806
$1.01+0.064+6.8%$0.96$1.044$0.96300,544
$0.946+0.005+0.6%$0.955$1.028$0.906413,727
$0.940.00-0.1%$0.983$0.984$0.94271,369
$0.941-0.199-17.5%$1.10$1.10$0.931,542,763
$1.14+0.03+2.7%$1.11$1.16$1.11210,402
$1.11-0.01-0.9%$1.14$1.17$1.11104,126
$1.12+0.02+1.8%$1.18$1.25$1.11280,419
$1.10-0.02-1.8%$1.12$1.12$1.0985,893
$1.120.000.0%$1.14$1.15$1.10118,463
$1.12-0.04-3.4%$1.14$1.19$1.1285,838
$1.160.000.0%$1.18$1.19$1.14160,805
$1.160.000.0%$1.18$1.197$1.1299,686
$1.16-0.03-2.5%$1.19$1.22$1.1470,498
$1.19-0.05-4.0%$1.23$1.23$1.15194,672
$1.24+0.03+2.5%$1.21$1.272$1.2070,138
$1.21-0.05-4.0%$1.26$1.285$1.18158,127
$1.26+0.01+0.8%$1.25$1.285$1.22119,057
$1.25+0.02+1.6%$1.23$1.27$1.21579,291
$1.23+0.01+0.8%$1.24$1.30$1.22171,011
$1.22+0.01+0.8%$1.30$1.31$1.20326,550
$1.21+0.06+5.2%$1.18$1.23$1.13293,297
$1.15+0.05+4.5%$1.13$1.16$1.08329,353

Splits

1 split · NASDAQ:CODX · every price before a split is adjusted for it

DayRatioWhat
1-for-30Consolidation
Ticker
NASDAQ:CODX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Co-Diagnostics, Inc. news

Co-Diagnostics, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
57 in the last 12 months · 223 in all · newest Nov 19, 2026 · oldest 2019
Calls
26 calls with a replay · 26 with a transcript · latest Nov 12, 2026
Decks
2 decks · latest Sep 16, 2026

Where Co-Diagnostics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CODX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CODXBOATSUnited StatesUSD
LSE:0A50LSEUnited KingdomUSD
LS Exchange:A41UNJLS ExchangeGermanyEUR
gettex:C970gettexGermanyEUR
Lang & Schwarz:A41UNJLang & SchwarzGermanyEUR
Munich:C970MunichGermanyEUR

Valuation

EV/sales 2.6× against a median of 1.6×: 5th lowest of 8 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$2.21M USD
P/E
Loss
EV/sales
2.6×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
20.3%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.2×
Beta vs S&P 500
2.16

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Co-Diagnostics, Inc. · NASDAQ:CODXUS$1.36MUS$2.21Mn/a2.6×n/a0.1×n/a0.2×2.16
Telo Genomics Corp. · TSXV:TELOUS$2.80MUS$2.12Mn/an/an/an/an/an/a0.04
Advanced Biomed Inc. · NASDAQ:ADVBUS$2.73MUS$3.12M0.5×12.2×n/a0.2×n/a0.1×0.35
Innovotech Inc. · TSXV:IOTUS$2.66MUS$2.51Mn/a1.0×n/a1.5×−21.1%0.1×0.39
Qlife Holding AB · OMXSTO:QLIFEUS$2.49MUS$2.88Mn/a34.1×n/a9.6×n/a3.1×n/a
Physiomics PLC · LSE:PYCUS$2.46MUS$1.91Mn/a1.6×n/a3.6×−74.1%0.0×n/a
20/20 BioLabs, Inc. · NASDAQ:AIDXUS$2.10M−US$1.01Mn/a−0.5×n/a3.4×−317.8%0.9×1.41
Bluejay Diagnostics, Inc. · NASDAQ:BJDXUS$1.90M−US$5.43Mn/an/an/a0.3×n/a0.0×1.71
Accustem Sciences Inc · OTC:ACUTUS$1.90MUS$1.88Mn/an/an/an/an/an/a0.19
InVitro International · OTC:IVROUS$1.87MUS$644,26029.6×0.8×14.0×1.1×8.2%0.0×0.17
Prostatype Genomics AB · OMXSTO:PROGENUS$1.36MUS$1.32Mn/a13.3×n/a2.1×n/a0.0×n/a
Median of the othersUS$2.28MUS$1.90M15.1×1.6×14.0×1.8×−47.6%0.0×0.35

Forecasts

1 buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
4.00 USD · Analysts' mean
EPS, year to Dec 2026
-3.10 · 1 analyst
Revenue, year to Dec 2026
654K · 1 analyst

Team and board

Officers

OfficerRole
Dwight H. EganChief Executive Officer
Richard AbbottPresident​
Andrew BensonHead of Investor Relations
Mayuranki AlmaulaSr. VP Overseas Operations and Strategic Alliances
Noriko KusukawaVice President
Christopher ThurstonChief Technology Officer
David NielsenChief Operations Officer​
Seth EganChief Commercialization Officer
Wes LindseyChief Scientific Officer

Board

DirectorRole
Carl WittwerChair

Events

Calls

CallWhenStatus
Co-Diagnostics (NASDAQ:CODX) Q3 2026 Earnings CallThu, Nov 12, 2026 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2026 Earnings CallThu, Aug 13, 2026 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q1 2026 Earnings CallThu, May 14, 2026 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2025 Earnings CallTue, Mar 31, 2026 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2025 Earnings CallThu, Nov 13, 2025 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2025 Earnings CallThu, Aug 14, 2025 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q1 2025 Earnings CallFri, May 09, 2025 · 2:30 AM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2024 Earnings CallThu, Mar 27, 2025 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2024 Earnings CallThu, Nov 07, 2024 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2024 Earnings CallThu, Aug 08, 2024 · 4:30 PM ETReplay
All 26 calls
CallWhenStatus
Co-Diagnostics (NASDAQ:CODX) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2023 Earnings CallThu, Mar 14, 2024 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2022 Earnings CallThu, Mar 16, 2023 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2022 Earnings CallThu, Nov 10, 2022 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2022 Earnings CallFri, Aug 12, 2022 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q1 2022 Earnings CallThu, May 12, 2022 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2021 Earnings CallThu, Mar 24, 2022 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2021 Earnings CallThu, Nov 11, 2021 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2021 Earnings CallThu, Aug 12, 2021 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q1 2021 Earnings CallThu, May 13, 2021 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q4 2020 Earnings CallThu, Mar 25, 2021 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q3 2020 Earnings CallMon, Nov 16, 2020 · 4:30 PM ETReplay
Co-Diagnostics (NASDAQ:CODX) Q2 2020 Earnings CallThu, Aug 13, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open−9.5%
Q2 2026Aug 13, 2026 · After close−6.0%
Q1 2026May 14, 2026 · After close−21.2%
Q4 2025Mar 19, 2026+12.1%
Q3 2025Nov 13, 2025 · After close−10.9%
Q2 2025Aug 14, 2025 · After close+10.8%
Q1 2025May 8, 2025 · After close−4.3%
Q4 2024Mar 12, 2025 · Before open+0.1%
Q3 2024Nov 7, 2024 · After close−3.4%
Q2 2024Aug 8, 2024 · After close+9.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−9.8%
Q4 2023Mar 14, 2024 · After close−10.1%
Q3 2023Nov 9, 2023 · After close−10.2%
Q2 2023Aug 10, 2023 · After close−4.1%
Q1 2023May 11, 2023 · After close+7.3%
Q4 2022Mar 16, 2023 · After close−16.2%
Q3 2022Nov 10, 2022 · After close+5.5%
Q2 2022Aug 11, 2022 · After close−30.6%
Q1 2022May 12, 2022 · After close+14.9%
Q4 2021Mar 24, 2022 · After close−11.6%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (September 2026)Corporate update14 slidesSep 16, 2026
Investor Presentation (2026)Investor deck16 slides2026

Open Decks

Financings

RaiseDate
Registered direct offering of shares of common stock (or pre-funded warrants in-lieu thereof)
Closed: US$7M raised · US$0.55 a share · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Oct 29, 2025
Registered direct offering of common stock
Closed: US$3.8M raised · US$0.4 a share · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Sep 18, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$6.00 a share on Jul 12, 2017.

Price
US$6.00 a share
Shares offered
1,178,532 shares of common stock
Offering size
US$7.1 million
Listing
CODX on the Nasdaq Capital Market
Underwriters
WallachBeth Capital, LLC, Network 1 Financial Securities, Inc., ViewTrade Securities, Inc. · In the order on the cover
Shares delivered
On or about Jul 17, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceJan 12, 2017
Filed publiclyApr 28, 2017
Amended 4 timesNewest Jul 10, 2017
Shares registered with an exchangeJul 11, 2017
Declared effective by the SECJul 11, 2017
Final prospectus, with the priceJul 13, 2017

Open IPO · From the cover of the final prospectus (424B4) filed Jul 13, 2017

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue622.5K3.92M6.81M34.2M97.9M74.6M215.0K39.9K7.66K0
Cost of revenue222.4K999.1K4.18M5.48M11.6M16.6M112.4K9.39K30237.5K
Gross profit400.1K2.92M2.63M28.7M86.3M58.0M102.5K30.5K7.36K-37.5K
Research and development19.1M21.0M23.0M17.4M15.0M3.19M1.37M1.36M1.00M731.5K
Selling, general and administrative9.06M16.2M14.3M14.3M11.6M8.28M3.50M3.57M3.10M796.9K
Operating income-50.2M-40.1M-42.7M-27.0M46.1M41.7M-5.89M-6.12M-4.56M-1.69M
Depreciation and amortization1.11M1.38M1.23M1.28M335.4K138.6K65.9K50.8K45.8K37.5K
EBITDA-49.1M-38.7M-41.5M-25.7M46.4M41.8M-5.83M-6.07M-4.52M-1.65M
Interest expense14.9M473.5K175106.4K71.0K310.2K240.7K
Income before tax-48.5M-37.6M-38.1M-18.8M45.6M42.6M-6.20M-6.27M-6.96M-1.93M
Income tax-1.62M57.4K-2.78M-4.61M8.98M90.5K-126.4K-19.0K293.8K0
Net income-46.9M-37.6M-35.3M-14.2M36.7M42.5M-6.20M-6.27M-6.96M-1.93M
Earnings per share, basic-35.25-37.22-1.20-0.451.271.59-0.37-0.50-0.63-0.20
Earnings per share, diluted-35.25-37.22-1.20-0.451.231.52-0.37-0.50-0.63

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents11.9M2.94M14.9M23.0M88.6M43.0M893.1K950.2K3.53M998.7K
Short-term investments026.8M43.6M58.3M1.26M4.34M0
Receivables190.4K132.6K303.9K3.45M20.8M12.1M131.4K13.4K3.18K
Inventory992.4K1.07M1.66M5.31M2.00M8.00M197.2K18.2K9.07K
Current assets13.7M32.3M62.1M92.7M115.1M67.8M1.58M1.05M4.45M1.21M
Property, plant and equipment2.27M2.76M3.04M2.54M1.93M949.6K196.8K156.1K165.6K87.4K
Goodwill014.7M00
Total assets24.7M63.6M95.3M123.1M160.0M71.2M2.22M1.55M4.66M1.30M
Accounts payable1.88M3.29M1.48M952.3K607.5K598.3K5.96K149.0K40.8K29.9K
Current liabilities3.54M7.32M5.75M3.87M12.6M4.06M328.1K2.35M628.3K3.85M
Long-term debt1.91M277.7K445.0K
Total debt1.24M2.15M2.99M347.9K3.82M2.56M
Total liabilities4.11M9.69M9.31M8.57M25.6M4.54M478.1K2.61M811.8K4.29M
Shareholders' equity20.6M53.9M85.6M114.5M134.5M66.7M1.74M-1.06M3.85M-2.99M
Shares outstanding2.10M1.10M31.3M30.9M33.8M28.6M17.3M12.9M12.3M9.88M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-29.1M-29.2M-22.1M6.57M41.1M28.2M-5.53M-4.08M-3.21M-1.31M
Capital spending-700.0K-748.4K-1.37M-1.43M-669.5K-774.4K-113.2K-41.3K-129.3K-12.2K
Free cash flow-29.8M-29.9M-23.4M5.14M40.4M27.4M-5.64M-4.12M-3.34M-1.32M
Cash from investing26.3M17.1M15.4M-58.2M4.10M-5.82M-435.2K-380.3K-189.3K-12.2K
Cash from financing11.8M103.9K-1.36M-14.0M450.4K19.7M5.90M1.88M5.94M2.29M
Dividends paid0
Share buybacks0-1.36M-14.2M450.4K19.7M5.90M30.0K7.07M7.07M
Change in cash8.95M-12.0M-8.06M-65.6M45.6M42.1M-57.1K-2.58M2.54M964.9K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 20, 2026Material contractSEC
8-K · Current reportNov 19, 2026Current reportSEC
8-K · Current reportNov 13, 2026Management or board changeSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026ResultsSEC
S-3 · Registration statementNov 4, 2026Offer documentSEC
DEF 14A · Proxy statementOct 26, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 19, 2026Meeting noticeSEC
8-K · Current reportOct 15, 2026Meeting outcomeSEC
8-K/A · Current report, amendedOct 15, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportOct 13, 2026Material contractSEC
8-K · Current reportOct 2, 2026Meeting outcomeSEC
8-K · Current reportSep 25, 2026Meeting outcomeSEC
PRE 14A · Preliminary proxy statementSep 21, 2026Meeting noticeSEC
8-K · Current reportSep 16, 2026Current reportSEC
8-K · Current reportSep 16, 2026Current reportSEC
8-K · Current reportSep 15, 2026Current reportSEC
3 · Initial statement of ownershipSep 14, 2026Insider tradeSEC
8-K · Current reportSep 4, 2026Management or board changeSEC
DEFA14A · Additional proxy materialSep 4, 2026Meeting noticeSEC
8-K · Current reportSep 4, 2026Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveSep 2, 2026Other filingsSEC
S-3 · Registration statementAug 24, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 10, 2026Big-stake noticeSEC
8-K · Current reportJul 31, 2026Material contractSEC
8-K · Current reportJul 27, 2026Material contractSEC
424B5 · ProspectusJul 27, 2026Offer documentSEC
DEF 14A · Proxy statementJul 21, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementJul 9, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeJun 3, 2026Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJun 1, 2026Other filingsSEC
CORRESP · Letter to the SECMay 28, 2026Other filingsSEC
S-3 · Registration statementMay 28, 2026Offer documentSEC
UPLOAD · Letter from the SECMay 28, 2026Other filingsSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
DRS · Draft registration statementMay 22, 2026Offer documentSEC
8-K · Current reportMay 21, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveMay 18, 2026Other filingsSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
CORRESP · Letter to the SECMay 13, 2026Other filingsSEC
S-3 · Registration statementMay 12, 2026Offer documentSEC
UPLOAD · Letter from the SECApr 14, 2026Other filingsSEC
DRS · Draft registration statementApr 10, 2026Offer documentSEC
10-K · Annual reportMar 31, 2026Annual reportSEC
8-K · Current reportMar 31, 2026ResultsSEC
8-K · Current reportMar 10, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansJan 21, 2026Offer documentSEC
8-K · Current reportJan 13, 2026Current reportSEC
8-K · Current reportDec 30, 2025Current reportSEC
424B5 · ProspectusDec 19, 2025Offer documentSEC
8-K · Current reportDec 5, 2025Meeting outcomeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeNov 13, 2025Big-stake noticeSEC
DEF 14A · Proxy statementNov 10, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 31, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
8-K · Current reportOct 29, 2025Material contractSEC
424B5 · ProspectusOct 28, 2025Offer documentSEC
8-K · Current reportOct 20, 2025Material contractSEC
424B5 · ProspectusOct 20, 2025Offer documentSEC
8-K · Current reportSep 30, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 19, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeSep 18, 2025Big-stake noticeSEC
8-K · Current reportSep 18, 2025Material contractSEC
424B5 · ProspectusSep 18, 2025Offer documentSEC
424B5 · ProspectusSep 16, 2025Offer documentSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025ResultsSEC
8-K · Current reportJul 11, 2025Current reportSEC
8-K · Current reportMay 29, 2025Meeting outcomeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
8-K · Current reportApr 28, 2025Material contractSEC
DEF 14A · Proxy statementApr 14, 2025Meeting noticeSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 27, 2025ResultsSEC
8-K · Current reportFeb 21, 2025Current reportSEC
8-K · Current reportJan 10, 2025Current reportSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
8-K/A · Current report, amendedNov 8, 2024Meeting outcomeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
424B5 · ProspectusOct 18, 2024Offer documentSEC
8-K · Current reportAug 30, 2024Meeting outcomeSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
DEF 14A · Proxy statementJul 16, 2024Meeting noticeSEC
8-K · Current reportJun 14, 2024Current reportSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 20, 2024Insider tradeSEC
8-K · Current reportMar 15, 2024Management or board changeSEC
10-K · Annual reportMar 14, 2024Annual reportSEC
8-K · Current reportMar 14, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 9, 2023ResultsSEC
8-K · Current reportAug 31, 2023Meeting outcomeSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 10, 2023ResultsSEC
DEF 14A · Proxy statementJul 20, 2023Meeting noticeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
4 · Change in ownershipMay 24, 2023Insider tradeSEC
8-K · Current reportMay 16, 2023Management or board changeSEC
4 · Change in ownershipMay 15, 2023Insider tradeSEC
4 · Change in ownershipMay 15, 2023Insider tradeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC
EFFECT · Notice that a registration is effectiveApr 7, 2023Other filingsSEC
8-K · Current reportApr 5, 2023Current reportSEC
CORRESP · Letter to the SECApr 4, 2023Other filingsSEC
UPLOAD · Letter from the SECMar 22, 2023Other filingsSEC
4 · Change in ownershipMar 21, 2023Insider tradeSEC
S-3 · Registration statementMar 16, 2023Offer documentSEC
10-K · Annual reportMar 16, 2023Annual reportSEC
8-K · Current reportMar 16, 2023ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
S-8 · Registration statement for employee plansJan 23, 2023Offer documentSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 19, 2023Insider tradeSEC
4 · Change in ownershipJan 9, 2023Insider tradeSEC
4 · Change in ownershipJan 9, 2023Insider tradeSEC
4 · Change in ownershipJan 9, 2023Insider tradeSEC
4 · Change in ownershipJan 9, 2023Insider tradeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC

This page holds 200 of 395 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Co-Diagnostics, Inc.’s releases · as of Nov 6, 2026

Common shares
10,512,190
Fully diluted
10,512,190

Fully diluted

LineSharesAs of
Common shares10,512,190Nov 6, 2026

Share count over time

CountShares
Nov 6, 202610,512,190
Sep 30, 20267,288,601

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard78,0510.74%US$83,514Sep 30, 2026
Geode Capital49,5990.47%US$53,070Sep 30, 2026
Private Advisory Group LLC39,3870.37%US$42,144Sep 30, 2026
Hrt Financial LP30,3550.29%US$32,000Sep 30, 2026
Citigroup Inc25,3010.24%US$27,072Sep 30, 2026
Jane Street24,0860.23%US$25,772Sep 30, 2026
Susquehanna15,9860.15%US$17,105Sep 30, 2026
State Street14,8000.14%US$15,836Sep 30, 2026
Tower Research Capital LLC (TRC)7,6840.07%US$8,222Sep 30, 2026
JPMorgan1,9930.02%US$2,132Sep 30, 2026
All 23 holders
HolderSharesOf the companyValueAs of
UBS1,4770.01%US$1,580Sep 30, 2026
Morgan Stanley1,4520.01%US$1,554Sep 30, 2026
SBI Securities Co., Ltd.140<0.01%US$150Sep 30, 2026
Smartleaf Asset Management LLC133<0.01%US$142Sep 30, 2026
Berthel, Fisher & Company Financial Services, Inc.100<0.01%US$107Sep 30, 2026
Wells Fargo81<0.01%US$87Sep 30, 2026
Osaic Holdings, Inc.10<0.01%US$10Sep 30, 2026
BFC Planning, Inc.8<0.01%US$9Sep 30, 2026
Pinnacle Financial Group, Inc.6<0.01%US$6Sep 30, 2026
NewEdge Advisors, LLC6<0.01%US$6Sep 30, 2026
Fidelity4<0.01%US$4Sep 30, 2026
Harbour Investments, Inc.2<0.01%US$2Sep 30, 2026
Northwestern Mutual Wealth Management Co1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund58,2750.55%US$181KJun 30, 2026
Fidelity Nasdaq Composite Index Fund39<0.01%US$333May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Armistice Capital, LLC9.99%560KJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andrew BensonHead of Investor Relations · Since at least Jul 16, 2026
Brent SatterfieldFormer Chief Science Officer · Jul 11, 2017 – Feb 23, 2021 · Past
Brian Lee BrownChief Financial Officer · Since at least May 23, 2025
Carl WittwerChair · Since at least Nov 4, 2026
Christopher ThurstonChief Technology Officer · Since at least Feb 4, 2026
Daniel BohrerEVP of Finance & Accounting · Since at least Sep 2, 2026
David NielsenChief Operations Officer​ · Since at least Nov 5, 2026
Dwight H. EganChief Executive Officer · Since at least Jul 11, 2017
Edward L MurphyDirector · Since at least Apr 24, 2019
Eugene DurenardDirector · Since at least Jul 11, 2022
All 20 people
PersonSeat
Frank J KiesnerDirector · Jul 11, 2017 – Jul 11, 2017 · Past
James B NelsonDirector · Since at least Sep 3, 2019
Mayuranki AlmaulaSr. VP Overseas Operations and Strategic Alliances · Since at least Nov 5, 2026
Noriko KusukawaVice President · Since at least Nov 4, 2026
Richard AbbottPresident​ · Since at least Mar 15, 2024
Richard S SerbinDirector · Since at least Jul 11, 2017
Seth EganChief Commercialization Officer · Since at least Sep 23, 2026
Ted MurphyDirector · Since at least Jan 8, 2022
Wes LindseyChief Scientific Officer · Since at least Jul 16, 2026
Wes LindseyChief Scientific Officer · Since Jul 16, 2026 · Appointed, no departure found

Open People

Log in to ask 6ix AI your own questions about Co-Diagnostics, Inc.